During the three-day Exchange agenda, esteemed leaders from the industry will come together to explore, discuss, and analyze the latest trends and controversies surrounding clinical pathways, oncology treatment, and the ever-evolving business of cancer care. The 2023 agenda shed light on crucial topics like:

• The Hunt for Value in Value-Based Cancer Care: How to Meet Stakeholders’ Evolving Demands

• Healthcare Industry Consolidation: The Impact on Cancer Care and Strategic Partnerships
   
• Reimagining Clinical Trials in the Community Setting 
   
• Genomic Testing, Pathways, and the Era of Precision Medicine
   
• Scaling Precision Medicine for Equitable Cancer Care: Breaking Barriers, Advancing Patient Outcomes
   
• The Evolving Role of Cost in Pathways: Cost of Care, Cost Avoidance, and Patient Costs 
   
• Leveraging Real-World Evidence to Improve Pathways: Pathways in Prostate Cancer Case Study 
   

Register today and be among the first to know when the 2024 agenda is released. If you are interested in speaking opportunities, please contact Kelly Jackson at kjackson@hmpglobal.com.